Related references
Note: Only part of the references are listed.Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives
Yvan Beaussant et al.
JOURNAL OF PALLIATIVE MEDICINE (2020)
Fostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness
William E. Rosa et al.
JOURNAL OF PALLIATIVE MEDICINE (2020)
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
Brian T. Anderson et al.
ECLINICALMEDICINE (2020)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C. Mithoefer et al.
PSYCHOPHARMACOLOGY (2019)
Ceremonial Plant Medicine' use and its relationship to recreational drug use: an exploratory study
Caroline Dorsen et al.
ADDICTION RESEARCH & THEORY (2019)
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care
William E. Rosa et al.
JOURNAL OF HOLISTIC NURSING (2019)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin L. Carhart-Harris et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Developing Guidelines and Competencies for the Training of Psychedelic Therapists
Janis Phelps
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M. Carbonaro et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
MDMA enhances emotional empathy and prosocial behavior
Cedric M. Hysek et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration
G. J. H. Dumont et al.
SOCIAL NEUROSCIENCE (2009)
The harmful health effects of recreational ecstasy: a systematic review of observational evidence
G. Rogers et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons
Gary A. Gudelsky et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans
R de la Torre et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
